Advanced Drug Delivery Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 21.0 | Q1 | 99.2% | 4.015 | Q1 | 98.6% |
| 2024 | 17.6 | Q1 | 99.2% | 3.721 | Q1 | 98.4% |
| 2023 | 15.2 | Q1 | 99.0% | 3.411 | Q1 | 98.3% |
| 2022 | 16.1 | Q1 | 99.0% | 2.982 | Q1 | 98.0% |
| 2021 | 17.9 | Q1 | 99.0% | 2.934 | Q1 | 98.0% |
| 2020 | — | — | 3.475 | Q1 | 98.3% | |
| 2019 | — | — | 4.082 | Q1 | 98.8% | |
| 2018 | — | — | 4.163 | Q1 | 98.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1872-8294
ISSN
0169-409X
region
Western Europe
coverage
1987-2026